1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

ArgenTAG

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2021

Location

New York NY US

Primary Industry

Biotechnology

About

Based in New York, US, and founded in 2021, ArgenTAG Corporation operates as a biotech company that develops innovative genomic sequencing applications using proprietary technology. In February 2022, ArgenTAG raised seed funding from investor SOSV. The company offers proprietary technology for long-read sequencing applications, including sequencing service, sequencing advisory, and sequencing kits.
Current Investors
GRID EXPONENTIAL, Draper University Ventures, SOSV

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Medical Software
Website
www.argentag.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.